Centhaquine for treating severe low blood pressure after blood loss
Treatments studied
This study tests a new medicine called centhaquine to help raise blood pressure and improve blood flow in people with severe low blood pressure due to fluid loss (hypovolemic shock). It is given alongside the standard emergency care you would already receive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have very low blood pressure (top number 90 or lower) that is not caused by an infection, heart problem, or nervous system issue.
- You must have an elevated blood lactate level (more than 2 mmol/L), which is a sign of poor circulation.
- You cannot be pregnant, have a do-not-resuscitate order, or have had CPR before the study starts.
- You cannot have serious pre-existing conditions like cancer, kidney or liver failure, heart failure, or AIDS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether centhaquine is safe and can help treat adults in the emergency room or ICU who have hypovolemic shock (dangerously low blood pressure from low circulating fluid). Participants receive the usual shock care, and the study adds this medicine to see if outcomes improve.
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
This study tests a new drug called centhaquine for people with severe breathing problems (ARDS) in the ICU. The drug may help improve oxygen levels and recovery, and the study compares it to the usual care alone.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This trial studies whether aiming for a higher average blood pressure (using medicines) can better protect kidney function in critically ill adults with shock. You may be asked to have close kidney and heart monitoring while receiving blood-pressure support.
Hear when a new Hypovolemic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.